secwatch.observer — SEC 8-K summary
======================================

Issuer:     Akoya Biosciences, Inc. (—)
CIK:        0001711933
Form:       8-K
Filed at:   2025-07-08T23:59:59+00:00
Accession:  0001104659-25-066306
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.95
Item codes: 1.02, 2.01, 3.01, 3.03, 5.03, 5.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Akoya Biosciences completes merger with Quanterix; shareholders receive 0.1461 QTRX shares + $0.38 cash per share
--------------------------------------------------------------------------------

- Merger closed July 8, 2025; Akoya is now a wholly owned subsidiary of Quanterix (QTRX).
- Per share: 0.1461 Quanterix shares plus $0.38 cash; adjustments ensure no more than 19.99% of QTRX shares or $20M cash issued.
- All outstanding Akoya RSUs and options converted or cancelled per merger agreement.
- Board and executive officers replaced with Quanterix appointees; Akoya common stock delisted from Nasdaq.
- Prior credit agreement, ESPP, and equity distribution agreement terminated in connection with merger.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711933/000110465925066306/0001104659-25-066306-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711933/000110465925066306/tm2520065d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-066306

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer